ISSN 2073–4034
eISSN 2414–9128

Use Of Nimesulide In The Therapy Of Rheumatoid Diseases

Yu.A. Olyunin

Use of nimesulide in the therapy of rheumatoid diseases
Nimesulide is widely used in 50 countries, including Russia and the EU. A number of clinical trials showed Nimesulide efficacy for correction of disorders associated with lesions of the peripheral joints, spine, periarticular soft tissues in patients with rheumatic diseases. In these studies, nimesulide was effective as other nonsteroidal anti-inflammatory drugs (NSAIDs), and caused a rapid response in patients. In addition, the pharmacokinetics of nimesulide characteristics (short half-life, lack of clinically significant accumulation) and the ability to selective cyclooxygenase-2 inhibition determine the general drug high tolerability. Analysis of the results of its use in general clinical practice shows that nimesulide significantly less likely cause adverse event on the gastrointestinal tract as compared with nonselective NSAIDs.

Keywords

rheumatic diseases
cyclooxygenase-2
non-steroidal anti-inflammatory drugs
nimesulide
rheumatoid arthritis
osteoarthritis

Similar Articles

By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.